Secondary Complications in COVID-19 Patients: A Case Series

Tomography. 2022 Jul 15;8(4):1836-1850. doi: 10.3390/tomography8040154.

Abstract

Introduction: Coronavirus SARS-CoV-2, the causative agent of COVID-19, primarily causes a respiratory tract infection that is not limited to respiratory distress syndrome, but it is also implicated in other body systems. Systemic complications were reported due to an exaggerated inflammatory response, which involves severe alveolar damage in the lungs and exacerbates the hypercoagulation that leads to venous thrombosis, ischemic attack, vascular dysfunction and infarction of visceral abdominal organs. Some complications are related to anticoagulant drugs that are administrated to stabilize hypercoagulability, but increase the risk of bleeding, hematoma and hemorrhage. The aim of this study is to report the diagnostic role of CT in the early diagnosis and management of patients with severe COVID-19 complications through the most interesting cases in our experience.

Material and methods: The retrospective analysis of patients studied for COVID-19 in our institution and hospitals, which are part of the university training network, was performed.

Cases: Pneumomediastinum, cortical kidney necrosis, splenic infarction, cerebral ischemic stroke, thrombosis of the lower limb and hematomas are the most major complications that are reviewed in this study.

Conclusions: Since the onset of the COVID-19 pandemic, the CT imaging modality with its high sensitivity and specificity remains the preferred imaging choice to diagnose early the different complications associated with COVID-19, such as thrombosis, ischemic stroke, infarction and pneumomediastinum, and their management, which significantly improved the outcomes.

Keywords: COVID-19; SARS-CoV-2; complications.

Publication types

  • Case Reports

MeSH terms

  • COVID-19* / complications
  • COVID-19* / diagnostic imaging
  • Humans
  • Infarction / complications
  • Ischemic Stroke*
  • Mediastinal Emphysema* / complications
  • Pandemics
  • Retrospective Studies
  • SARS-CoV-2
  • Stroke* / etiology
  • Thrombosis* / complications

Grants and funding

This research received no external funding.